Retirement Planning CO Of New England, Inc. Gilead Sciences, Inc. Transaction History
Retirement Planning CO Of New England, Inc.
- $197 Million
- Q3 2024
A detailed history of Retirement Planning CO Of New England, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Retirement Planning CO Of New England, Inc. holds 11,045 shares of GILD stock, worth $996,148. This represents 0.47% of its overall portfolio holdings.
Number of Shares
11,045
Previous 12,342
10.51%
Holding current value
$996,148
Previous $846,000
9.34%
% of portfolio
0.47%
Previous 0.47%
Shares
12 transactions
Others Institutions Holding GILD
# of Institutions
1,923Shares Held
994MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$10.9 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.4 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$6.9 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.57 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.43 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $113B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...